PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.43%
Revenue growth above 1.5x 3391.T's 0.68%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-0.51%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
51.44%
Positive EBIT growth while 3391.T is negative. John Neff might see a substantial edge in operational management.
1.06%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
52.44%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
52.44%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
52.44%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.00%
Share reduction more than 1.5x 3391.T's 0.11%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 3391.T's 0.05%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
52.55%
10Y revenue/share CAGR under 50% of 3391.T's 195.95%. Michael Burry would suspect a lasting competitive disadvantage.
59.61%
5Y revenue/share CAGR similar to 3391.T's 65.40%. Walter Schloss might see both companies benefiting from the same mid-term trends.
26.86%
3Y revenue/share CAGR similar to 3391.T's 26.81%. Walter Schloss would assume both companies experience comparable short-term cycles.
100.00%
Positive long-term OCF/share growth while 3391.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
222.32%
Net income/share CAGR 1.25-1.5x 3391.T's 154.60%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
177.62%
5Y net income/share CAGR above 1.5x 3391.T's 1.67%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
107.89%
Positive short-term CAGR while 3391.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
194.93%
10Y equity/share CAGR in line with 3391.T's 214.61%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
125.91%
5Y equity/share CAGR above 1.5x 3391.T's 69.19%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.94%
3Y equity/share CAGR above 1.5x 3391.T's 37.22%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while 3391.T invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
10.26%
Our AR growth while 3391.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-1.27%
Inventory is declining while 3391.T stands at 0.09%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.24%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.71%
BV/share growth above 1.5x 3391.T's 0.56%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.89%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-0.94%
We cut SG&A while 3391.T invests at 1.80%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.